Healing begins
with a single cell.™
Stemagen First to Create Cloned Human Embryos from Adult Cells
| Major advancement towards creating patient-specific and disease-specific stem cells for therapeutic use. |
Download complete article here
DOWNLOAD HIGH RESOLUTION IMAGES HERE
Novel embryonic stem cell lines created from unfertilized embryos may be an acceptable alternative for those opposed to embryonic stem cell research. |
Download complete article here
House Passes Bill to Expand Stem Cell Funding
Stemagen today commends the U.S. House of Representatives for overwhelmingly passing House Resolution 3, which would expand federal funding for embryonic stem cell research. While the measure failed to pass with enough votes to override an expected Presidential veto, it did enjoy broad bipartisan support. |
Download complete article here
Australian Senate Approves Embryonic Stem Cell Research
Stemagen CSO Andrew French, Ph.D., is interviewed by The Age, Melbourne's paper of record, on his thoughts regarding the Australian government taking steps to approve embryonic stem cell research. |
Download complete article here
Stemagen CEO Writes Letter to Governor Regarding Senate Bill 1260
Samuel Wood, M.D., Ph.D., writes letter to Governor Schwarzenegger regarding Senate Bill 1260 and the detrimental effect it will have, if passed, on women's equality and California's burgeoning stem cell research industry. |
Download complete article here
Stemagen Announces Important Institutional Review Board Approval
Stemagen, a company dedicated to the production of therapeutic stem cells, announced today it has received Institutional Review Board (IRB) approval to develop embryonic stem cells using a comprehensive set of methods, including the process of Somatic Cell Nuclear Transfer (SCNT) for “therapeutic cloning.” Stemagen also received approval to use excess fresh eggs, which have shown in previous research to offer the greatest chance of successfully completing the therapeutic cloning process. |
Download complete article here
| Human therapeutic cloning or nuclear transfer stem cells (NTSC) to produce patient-specific stem cells, holds considerable promise in the field of regenerative medicine. |